Legal Opinion
Apotex, Inc. v. Food & Drug Administration
Court of Appeals for the D.C. Circuit
Decided December 21, 2004No. 04-5211PublishedCited by 178 opinions
1Opinion of the Court
HARRY T. EDWARDS, Circuit Judge.
Since December 2002, the District Court has issued three decisions in connection with disputes between Apotex, Inc. (“Apo-tex”) and Purepac Pharmaceutical Co. (“Purepac”) over the marketing of a generic version of the drug gabapentin., The Food and Drug Administration (“FDA” or “agency”) has approved gabapentin, sold by Pfizer, Inc. (“Pfizer”) under the brand name Neurontin, for the treatment of epilepsy. The first two decisions, Purepac Pharmaceutical Co. v. Thompson, 238 F.Supp.2d 191 (D.D.C.2002) (“Purepac I ”), and TorPharm, Inc. v. Thompson, 260…
2Cases cited14 opinions
- Allen v. McCurrySupreme Court of the United States · 1980
- Montana v. United StatesSupreme Court of the United States · 1979
- Federated Department Stores, Inc. v. MoitieSupreme Court of the United States · 1981
- Heiser v. WoodruffSupreme Court of the United States · 1946
- Richard Drake v. Federal Aviation AdministrationCourt of Appeals for the D.C. Circuit · 2002
9 more not listed; retrieve them via the Exa API.
3Cited by178 opinions
- In Re Islamic Republic of Iran Terrorism LitigationDistrict Court, District of Columbia · 2009
- Peters v. District of ColumbiaDistrict Court, District of Columbia · 2012
- Sturdza v. United Arab EmiratesDistrict Court, District of Columbia · 2009
- McCain v. Bank of AmericaCourt of Appeals for the D.C. Circuit · 2014
- Lewis v. Drug Enforcement AdministrationDistrict Court, District of Columbia · 2011
173 more not listed; retrieve them via the Exa API.